Registration Open for PRaISE Student Research Conference
Registration is now open for the 15th annual Presentation of Research and Innovative/Scholarly Endeavors (PRaISE) Conference, held by the College of Allied Health Sciences.
The conference keynote speaker will be Graham Hughes, MD, is the Chief Medical Officer within SAS (Statistical Analysis Software) Institute's Center for Health Analytics & Insights.
Hughes has over 20 years' experience developing and delivering innovative healthcare IT products and services and has a deep understanding of healthcare market dynamics, both in the UC and internationally.
Immediately prior to joing SAS in June 2011, he spent six years working as VP of Product Strategy and Chief Medical Informatics Officer at GE Healthcare IT, leading a "Customer Encounter with Advanced Technology" innovation team as well as spearheading the annual strategic planning process for GEHCIT's enterprise portfolio of products.
Students can register online at cahs.uc.edu/current/praise-register.aspx until at 5 p.m. Wednesday, March 13.
For the full schedule and more information, visit cahs.uc.edu/current/praise.aspx.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.